Concepedia

M E van der Burg

ME

Statistics

Publications

5

Citations

244

H-Index

5

Active since

1995

Affiliations

Rotterdam University of Applied Sciences(Current)

M E van der Burg is an author at Rotterdam University of Applied Sciences specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1995–2000

5

Publications

5

The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.

Lia van Zuylen, Alex Sparreboom, Ate van der Gaast et al. · PubMed · 2000 · 100 citations

, , +11

A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin)

C J Gerrits, Jan H.M. Schellens, Howard A. Burris et al. · PubMed · 1999 · 65 citations

, , +17

Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.

C J Gerrits, Howard A. Burris, Jan H.M. Schellens et al. · PubMed · 1998 · 37 citations

, , +16

High-dose epirubicin in platinum-pretreated patients with ovarian carcinoma: the EORTC-GCCG experience.

J. B. Vermorken, A Kobierska, M E van der Burg et al. · PubMed · 1995 · 25 citations

Drug-administration sequence does not change pharmacodynamics and kinetics of irinotecan and cisplatin.

Maja J. De Jonge, Jaco J. Verweij, A. S. T. Planting et al. · PubMed · 1999 · 17 citations

, , +16

1–5 of 5